Literature DB >> 23248048

Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.

Kazuyo Kohama1, Makiko Kawaguchi, Tsuyoshi Fukushima, Chen-Yong Lin, Hiroaki Kataoka.   

Abstract

Hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor Kunitz type 1 (HAI-1/SPINT1) is a membrane-bound Kunitz-type serine protease inhibitor that is abundantly expressed on the surface of cytotrophoblasts, and is critically required for the formation of the placenta labyrinth in mice. HAI-1/SPINT1 regulates several membrane-associated cell surface serine proteases, with matriptase being the most cognate target. Matriptase degrades extracellular matrix protein such as laminin and activates other cell surface proteases including prostasin. This study aimed to analyze the role of HAI-1/SPINT1 in pericellular proteolysis of trophoblasts. In HAI-1/SPINT1-deficient mouse placenta, laminin immunoreactivity around trophoblasts was irregular and occasionally showed an intense punctate pattern, which differed significantly from the linear distribution along the basement membrane observed in wild-type placenta. To explore the molecular mechanism underlying this observation, we analyzed the effect of HAI-1/SPINT1 knock down (KD) on pericellular proteolysis in the human trophoblast cell line, BeWo. HAI-1/SPINT1-KD BeWo cells had increased amounts of cellular laminin protein and decreased laminin degradation activity in the culture supernatant. Subsequent analysis indicated that cell-associated matriptase was significantly decreased in KD cells whereas its mRNA level was not altered, suggesting an enhanced release and/or dislocation of matriptase in the absence of HAI-1/SPINT1. Moreover, prostasin activation and pericellular total serine protease activities were significantly suppressed by HAI-1/SPINT1 KD. These observations suggest that HAI-1/SPINT1 is critically required for the cell surface localization of matriptase in trophoblasts, and, in the absence of HAI-1/SPINT1, physiological activation of prostasin and other protease(s) initiated by cell surface matriptase may be impaired.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23248048     DOI: 10.1007/s13577-012-0055-2

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  36 in total

1.  TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.

Authors:  Tomio Hashimoto; Minoru Kato; Takeshi Shimomura; Naomi Kitamura
Journal:  FEBS J       Date:  2010-10-26       Impact factor: 5.542

2.  Epithelial sodium channel in a human trophoblast cell line (BeWo).

Authors:  Silvana del Mónaco; Yanina Assef; Basilio A Kotsias
Journal:  J Membr Biol       Date:  2008-07-30       Impact factor: 1.843

3.  Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta.

Authors:  H Kataoka; J Y Meng; H Itoh; R Hamasuna; T Shimomura; T Suganuma; M Koono
Journal:  Histochem Cell Biol       Date:  2000-12       Impact factor: 4.304

4.  Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

Authors:  Daniel Kirchhofer; Mark Peek; Michael T Lipari; Karen Billeci; Bin Fan; Paul Moran
Journal:  FEBS Lett       Date:  2005-03-28       Impact factor: 4.124

5.  Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.

Authors:  R Szabo; A Molinolo; K List; T H Bugge
Journal:  Oncogene       Date:  2006-09-18       Impact factor: 9.867

6.  Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin.

Authors:  Bin Fan; Thomas D Wu; Wei Li; Daniel Kirchhofer
Journal:  J Biol Chem       Date:  2005-08-15       Impact factor: 5.157

7.  Matriptase activation, an early cellular response to acidosis.

Authors:  I-Chu Tseng; Han Xu; Feng-Pai Chou; Gong Li; Alexander P Vazzano; Joseph P Y Kao; Michael D Johnson; Chen-Yong Lin
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

8.  Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice.

Authors:  Karin List; Brooke Currie; Tiffany C Scharschmidt; Roman Szabo; Jessica Shireman; Alfredo Molinolo; Benjamin F Cravatt; Julia Segre; Thomas H Bugge
Journal:  J Biol Chem       Date:  2007-10-16       Impact factor: 5.157

9.  Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.

Authors:  Koki Nagaike; Makiko Kawaguchi; Naoki Takeda; Tsuyoshi Fukushima; Akira Sawaguchi; Kazuyo Kohama; Mitsuru Setoyama; Hiroaki Kataoka
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

10.  Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.

Authors:  Roman Szabo; Katiuchia Uzzun Sales; Peter Kosa; Natalia A Shylo; Sine Godiksen; Karina K Hansen; Stine Friis; J Silvio Gutkind; Lotte K Vogel; Edith Hummler; Eric Camerer; Thomas H Bugge
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

View more
  5 in total

1.  Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.

Authors:  Makiko Kawaguchi; Ai Kanemaru; Akira Sawaguchi; Koji Yamamoto; Takashi Baba; Chen-Yong Lin; Michael D Johnson; Tsuyoshi Fukushima; Hiroaki Kataoka
Journal:  Am J Pathol       Date:  2015-04-01       Impact factor: 4.307

Review 2.  Mechanisms of hepatocyte growth factor activation in cancer tissues.

Authors:  Makiko Kawaguchi; Hiroaki Kataoka
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

3.  Circulating SPINT1 Is Reduced in a Preeclamptic Cohort with Co-Existing Fetal Growth Restriction.

Authors:  Ciara N Murphy; Catherine A Cluver; Susan P Walker; Emerson Keenan; Roxanne Hastie; Teresa M MacDonald; Natalie J Hannan; Fiona C Brownfoot; Ping Cannon; Stephen Tong; Tu'uhevaha J Kaitu'u-Lino
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

Review 4.  Pluripotency and Growth Factors in Early Embryonic Development of Mammals: A Comparative Approach.

Authors:  Lola Llobat
Journal:  Vet Sci       Date:  2021-05-04

5.  Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.

Authors:  Jingjia Ye; Makiko Kawaguchi; Yukihiro Haruyama; Ai Kanemaru; Tsuyoshi Fukushima; Koji Yamamoto; Chen-Yong Lin; Hiroaki Kataoka
Journal:  Cancer Sci       Date:  2013-11-25       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.